Skip to main content

and
  1. Article

    Open Access

    Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma

    A postprandial increase of translation mediated by eukaryotic Initiation Factor 6 (eIF6) occurs in the liver. Its contribution to steatosis and disease is unknown. In this study we address whether eIF6-driven ...

    Alessandra Scagliola, Annarita Miluzio, Gabriele Ventura in Nature Communications (2021)

  2. Article

    Open Access

    Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver

    Increased adiposity confers risk for systemic insulin resistance and type 2 diabetes (T2D), but mechanisms underlying this pathogenic inter-organ crosstalk are incompletely understood. We find PHLPP2 (PH domai...

    Kyeong** Kim, ** Ku Kang, Young Hoon Jung, Sang Bae Lee in Nature Communications (2021)

  3. Article

    Open Access

    The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

    There is a high unmet need for develo** treatments for nonalcoholic fatty liver disease (NAFLD), for which there are no approved drugs today. Here, we used a human in vitro disease model to understand mechanism...

    Sebastian Prill, Andrea Caddeo, Guido Baselli, Oveis Jamialahmadi in Scientific Reports (2019)

  4. Article

    Open Access

    The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis

    The impact of Transmembrane 6 superfamily member 2 (TM6SF2) E167K variant, which causes hepatocellular fat retention by altering lipoprotein secretion, on liver damage and metabolic traits in chronic hepatitis C ...

    Zhengtao Liu, Shu** Que, Lin Zhou, Shusen Zheng, Stefano Romeo in Scientific Reports (2017)

  5. Article

    Open Access

    MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

    Nonalcoholic fatty liver disease (NAFLD) represents an emerging cause of hepatocellular carcinoma (HCC), especially in non-cirrhotic individuals. The rs641738 C > T MBOAT7/TMC4 variant predisposes to progressive ...

    Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni in Scientific Reports (2017)